ResearcherFujian Medical UniversityNo recent work listed

Ranjie Yu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5087790556. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2017: 1 paper

Papers 1

Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.prp.2017.04.024 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xuenong Ouyang · 1 shared paper, 2017 · strength 0.06
- Paper Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma. DOI 10.1016/j.prp.2017.04.024 ↗
Qun Chen · 1 shared paper, 2017 · strength 0.06
- Paper Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma. DOI 10.1016/j.prp.2017.04.024 ↗
Jie Li · 1 shared paper, 2017 · strength 0.06
- Paper Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma. DOI 10.1016/j.prp.2017.04.024 ↗
Xiong Chen · 1 shared paper, 2017 · strength 0.06
- Paper Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma. DOI 10.1016/j.prp.2017.04.024 ↗
Yan Zhang · 1 shared paper, 2017 · strength 0.06
- Paper Clinicopathologic features and prognostic implications of MYBL2 protein expression in pancreatic ductal adenocarcinoma. DOI 10.1016/j.prp.2017.04.024 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.